Table 3.
Names of the Authors (Year of Publication) | Sample Size | Potential Sub-Sampling of Sample of Interest (Between-Person) | Experi-mental Condition (Within-Person) | Cycle Phases Compared | Potential Validation Of Cycle Phase | Measure Indexing CVA | Body Position During CVA Assessment | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Menstrual | Mid-To-Late Follicular | Ovulatory | Early-To-Mid Luteal | Premenstrual | |||||||
Abidi et al. (2017) [58] | 12 | - | - | “Low hormone”: Day 2–5 |
“High hormone”: Day 18–24 |
HFnu | Supine | ||||
Armbruster et al. (2018) [59] | 45 | - | - | “Early follicular”: Day 1–7 |
“Late luteal”: Day 6–1 before menstrual onset |
Saliva hormone analyses of E2, P4, Testosterone | RMSSD | Sitting | |||
Bai et al. (2009) [60] | 16 | - | - | “Follicular”: Day = 11.9 ± 1.4; range 10–14 |
“Luteal”: Day = 22.0 ± 1.4; range 20–24 |
Blood hormone analyses of E2 and P4 | HF in ms2 | Supine | |||
Baker et al. (2008) [61] | 21 | PMS versus Controls | - | “Mid-follicular” Day 6–12 |
“Late-luteal” Day 9–13 after LH-surge |
Blood hormone analyses of P4 | RMSSD | Supine | |||
Balayssac-Siransy et al. (2014) [40] | 14 | - | Active Recovery 3rd min | “Menstrual”: Day = 2.9 ± 0.6; range 1–5 |
“Follicular”: Day = 13.0 ± 1.4; 4 days preceding ovulation |
“Luteal”: Day = 23.1 “Luteal” 1.4; 6–10 days after ovulation |
Blood hormone analyses of E2 and P4 | HRR | Sitting | ||
Brar et al. (2015) [62] | 50 | - | - | “Menstrual”: Day = 2 |
“Proliferative”: Day = 10 |
“Secretory”: Day = 21 |
RMSSD | Sitting | |||
Choudhary et al. (2016) [63] | 100 | Eggetarians versus Non-vegetarians versus Vegetarians | - | “Menses”: Day 1–2 |
“Follicular”: Day 7–10 |
“Luteal”: Day 7–3 days before menstrual onset |
HF in ms2 | Supine | |||
Chung & Yang (2011) [44] | 12 | - | Day Shift | “Menses”: Day 1–2 |
“Follicular”: Day 7–10 |
“Luteal”: Day 7–3 before menstrual onset |
Blood hormone analyses of E2 and P4 | HF in ms2 | 24 h | ||
Cooke et al. (2002) [50] | 10 | - | - | Day 0–8 | Day 9–14 | Day 15–20 | Day 21–25 | Blood hormone analyses of E2 and P4 | BS | Supine | |
De Zambotti et al. (2013) [42] | 26 | PMS versus Controls | REM sleep | “Mid-follicular”: Day 6–11 |
“Mid-luteal”: Day 5–9 after LH-surge on average 8 ± 2 days before menstrual onset |
“Late-luteal”: Day 10–14 after LH-surge on average 3 ± 2 days before menstrual onset |
Blood hormone analyses of E2 and P4 | lnHF | Supine | ||
Devaki et al. (2014) [64] | 15 | - | - | “Menstrual”: Day 1–5 |
“Proliferative”: Day 9–12 |
“Secretory”: Day 19–22 |
HFnu | Supine | |||
Dimitriev et al. (2007) [65] | 10 | - | - | “Follicular”: Day 7–11 |
“Luteal”: Day 7–3 before menstrual onset |
HF in ms2 | n/a | ||||
Grrishma et al. (2015) [66] | 60 | - | - | “Follicular”: Day 8–10 |
“Luteal”: Day 5–1 before menstrual onset |
HF in ms2 | Supine | ||||
Guasti et al. (1999) [67] | 13 | - | - | “Follicular” Day 4–6 |
“Luteal”: Day 20–26 |
HFnu | Supine | ||||
Huang et al. (2015) [68] | 10 | - | - | “Mid-follicular”: n/a |
“Mid-luteal”: n/a |
Blood hormone analyses of P4 | HFnu | n/a | |||
Konishi et al. (2008) [69] | 12 | - | - | “Postmenstrual”: Day 3–7 after cessation of bleeding |
“Premenstrual”: Day 10–3 before menstrual onset |
HF in ms2 | Seated | ||||
Kulshreshtha et al. (2013) [53] | 45 | PMS versus Controls | - | “Follicular”: Day = 7 |
“Luteal”: Day = 21 |
DBT | n/a | ||||
Landén et al. (2004) [70] | 39 | PMDD versus Controls | - | “Follicular”: Day 6–10 |
“Luteal”: Day 5–0 before menstrual onset |
RMSSD | 24 h | ||||
Leicht et al. (2003) [71] | 10 | - | - | “Menses”: Day = 3.8 ± 0.5; range 1–5 |
“Ovulation”: Day = 15.8 ± 0.7; range 11–21 |
“Luteal”: Day = 22.1 ± 0.4; range 21–24 |
Blood hormone analyses of E2 and P4 | HF in ms2 | Supine | ||
Liu et al. (2013) [72] | 27 | High versus Low Neuroticism | - | “Menstruation”: Day 1–4 |
“Ovulation”: Day 11–13 |
“Luteal”: Day 21–22 |
HFnu | n/a | |||
Lüthi et al. (2008) [49] | 10 | - | - | “Follicular”: Day 3–6 |
“Mid-cycle”: Day of/day after LH-surge |
“Luteal”: Day 6–8 after LH-surge |
Blood hormone analyses of E2 and P4 | RSA | Seated | ||
Matsumoto et al. (2006) [73] | 30 | High versus Middle versus Low Premenstrual Symptomatology | - | “Follicular”: Day 1–5 |
“Late luteal”: Day 7–1 before menstrual onset |
Urinary hormone analyses of E2 and P4 | HF in ms2 | Supine | |||
McKinley et al. (2009) [74] | 49 | - | - | “Early-to-mid-follicular”: Day 4–10 |
“Mid-luteal”: Day 3 after LH-surge–5 days before menstrual onset |
logRMSSD | 24 h | ||||
Minson et al. (2000) [51] | 9 | - | - | “Early follicular”: Day 2–4 |
“Midluteal”: Day 8–10 after LH-surge |
Blood hormone analyses of E2, P4, LH, follicle stimulating hormone | CBS | Supine | |||
Nakagawa et al. (2006) [75] | 11 | - | - | “Follicular”: Day = 9.5 ± 0.5; range 7–12 |
“Luteal”: Day = 23.2 ± 0.8; range 18–26 |
Blood hormone analyses of E2 and P4 | RMSSD | n/a | |||
Nakamura et al. (2013) [76] | 18 | Athlete versus Control | - | “Early follicular”: Day 4–8 |
“Middle luteal”: Day 5–10 after ovulation |
lnHF | Supine | ||||
Ohara et al. (2015) [45] | 7 | - | Eating Trial | “Follicular”: n/a |
“Luteal”: n/a |
HF in ms2 | Supine | ||||
Pestana et al. (2018) [77] | 19 | - | - | “Menstrual”: Day 1–9 |
“Luteal”: Day 15-day before menstrual onset |
HFnu | Supine | ||||
Princi et al. (2005) [78] | 6 | - | - | “Menstrual”: Day 3“Follicular”: Day 7 |
“Luteal”: Day 21 |
Blood hormone analyses of E2 and P4 | HF in ms2 | Sitting | |||
Rawal & Saini (2014) [79] | 20 | - | - | “Menstrual”: n/a |
“Follicular”: n/a |
“Luteal”: n/a |
RMSSD | Supine | |||
Saeki et al. (1997) [80] | 10 | - | - | “Menstrual”: Day 1–3 |
“Follicular”: Period between menstrual and ovulatory phases |
“Ovulatory”: Period of 4 days beginning 3 days prior to the day of ovuluation |
“Luteal”: Period between ovulatory and premenstrual phases |
“Premenstrual”: Days 7–1 before menstrual onset |
Blood hormone analyses of E2 and P4 | HF in sec2 | Supine |
Sato & Miyake (2004) [81] | 14 | - | - | “Follicular”: Day 7–11 |
“Luteal”: Days 7–3 before menstrual onset |
HF in ms2 | Sitting | ||||
Sato et al. (1995) [82] | 20 | - | - | “Follicular”: Day 7–10 |
“Luteal”: Days 7–3 before menstrual onset |
Blood hormone analyses of P4 | HF in ms2 | Sitting | |||
Seebauer et al. (2002) [83] | 26 | Low versus medium versus high average HR | “Menstruation”: Day 1–4 |
“Early follicular”: Remaining days between end of menses and mid-follicular phase “Mid-follicular”: 3 days preceding late follicular phase “Late follicular”: 3 days preceding ovulation phase |
“Ovulation”: Positive test result ± 1 day (duration 3 days) | “Early luteal”: 4 days following ovulation phase “Mid-luteal”: 4 days following ovulation phase |
“Late-luteal”: Remaining days between end of mid-luteal phase and onset of menses |
logRSA | Supine | ||
Shetty et al. (2010) [84] | 54 | - | - | “Menstrual”: Day 1–5 |
“Follicular”: Day 6–14 |
“Luteal”: Day 15–28 or menstrual onset |
HF in ms2 | Supine | |||
Teixeira et al. (2015) [52] | 13 | - | - | “Early follicular”: Day = 3.6 ± 1.2; range 1–5 |
“Ovulatory”: Day = 14.3 ± 08; range 13–16 |
“Mid-luteal”: Day = 21.3 ± 0.8; range 20–24 |
Blood hormone analyses of E2 and P4 | CVI | Supine | ||
Tenan et al. (2014) [85] | 13 | - | - | “Early follicular”: Equally spaced with late follicular phase from menstrual onset until ovulatory phase |
“Late follicular”: Equally spaced with early follicular phase from menstrual onset until ovulatory phase |
“Ovulatory”: 3-day period |
“Midluteal”: Equally spaced with late luteal phase from end of ovulatory phase until menstrual onset |
“Late luteal”: Equally spaced with early luteal phase from end of ovulatory phase until menstrual onset |
lnHF | Sitting | |
Tousignant-Laflamme & Marchand (2009) [86] | 29 | - | - | “Menstrual”: Day 1–3 |
“Ovulatory”: Day 12–14 |
“Luteal”: Day 19–23 |
Blood hormone analyses of E2 and P4 | HF in ms2 | Sitting | ||
Usha Rani et al. (2013) [87] | 50 | - | - | “Menstrual”: Day 1–5 |
“Follicular”: Day 6–14 |
“Luteal”: Day 15–28 |
HFnu | n/a | |||
Veldhuijzen von Zanten et al. (2009) [88] | 12 | - | - | “Follicular”: Day 4–9 |
“Luteal”: Day 19–25 |
Blood hormone analyses of E2 and P4 | RMSSD | Supine | |||
Verma et al. (2018) [54] | 50 | - | - | “Menstrual”: Day 1–5 |
“Follicular”: Day 9–12 |
“Luteal phase”: Day 19–25 |
Valsalva | Sitting | |||
Voronova et al. (2015) [43] | 21 | - | Spring | “Early follicular”: Day 7 |
“Late follicular”: Day 13 “Ovulation”: Day 16 |
“Luteal”: Day 24 |
RMSSD | Supine | |||
Weissman et al. (2009) [57] | 14 | “Early follicular”: Day 2–3 |
“Preovulatory”: Just before ovulation |
Blood hormone analyses of E2 | HFnu | Supine | |||||
Yazar (2016) [89] | 30 | - | - | “Late follicular”: Day 9–13 |
“Mid-luteal”: Day 19–23 |
RMSSD | n/a | ||||
Yildirir et al. (2001) [90] | 43 | - | - | “Follicular”: Day 10–12 |
“Luteal”: Day 19–23 |
HF in m/sn2 | Supine |
Note. PMDD = premenstrual dysphoric disorder; PMS = premenstrual syndrome; PS = premenstrual symptomatology; LH = luteinizing hormone; E2 = estradiol; P4 = progesterone; RMSSD = root mean square of successive differences between adjacent RR intervals; HF = high frequency component in the power spectrum range; HRR = heart rate reactivity; CVI = cardiac vagal index; DBT = deep breathing test; Valsalva = Valsalva ratio; BS = baroreflex slope; RSA = respiratory sinus arrhythmia; CBS = cardiovagal baroreflex sensitivity; n/a = information not available.